Angiotensin receptor-neprilysin inhibiton (ARNI) - A novel therapeutic concept for management of hypertension and heart failure

被引：8

作者：

Kjeldsen, Sverre E. ^{[1
]}

Hedner, Thomas ^{[2
]}

Narkiewicz, Krzysztof ^{[3
]}

Oparil, Suzanne ^{[4
]}

机构：

[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, N-0407 Oslo, Norway

[2] Univ Gothenburg, Sahlgrenska Acad, Dept Med, Gothenburg, Sweden

[3] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland

[4] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL USA

来源：

BLOOD PRESSURE | 2012年 / 21卷 / 06期

关键词：

NATRIURETIC-PEPTIDE; SYSTEM; BIOLOGY; TARGET; LCZ696;

D O I：

10.3109/10582452.2012.741765

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：329 / 330

页数：2

共 40 条

[1] Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?
Ali, Ayan
Ortega-Legaspi, Juan M.
ANNALS OF PALLIATIVE MEDICINE, 2022,
[2] Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
Sutanto, Henry
Dobrev, Dobromir
Heijman, Jordi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
[3] Angiotensin Receptor-Neprilysin Inhibition: New Therapeutic Concept for the Management of Chronic Heart Failure: Development, Clinical Implications, and Future Perspectives
Havakuk, Ofer
Elkayam, Uri
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (04) : 356 - 364
[4] Effects of angiotensin receptor-neprilysin inhibitor on insulin resistance in patients with heart failure
Kashiwagi, Yusuke
Nagoshi, Tomohisa
Kimura, Haruka
Tanaka, Yoshiro
Oi, Yuhei
Inoue, Yasunori
Ogawa, Kazuo
Kawai, Makoto
Yoshimura, Michihiro
ESC HEART FAILURE, 2023, 10 (03): : 1860 - 1870
[5] The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond
Kario, Kazuomi
CURRENT CARDIOLOGY REPORTS, 2018, 20 (01)
[6] Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure
Ding, Kun
Gui, Yang
Hou, Xu
Ye, Lifang
Wang, Lihong
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[7] Diuretic and renal effects of angiotensin receptor-neprilysin inhibitor in patients hospitalized for acute heart failure
Setoguchi, Naoto
Horiuchi, Yu
Kawakami, Toshiharu
Nakase, Masaaki
Watanabe, Yusuke
Ishizawa, Taiki
Sekiguchi, Masahiro
Nakajima, Momoka
Nonaka, Hideaki
Asami, Masahiko
Yahagi, Kazuyuki
Komiyama, Kota
Yuzawa, Hitomi
Tanaka, Jun
Aoki, Jiro
Tanabe, Kengo
HEART AND VESSELS, 2023, 38 (08) : 1042 - 1048
[8] In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial
Tanaka, Atsushi
Kida, Keisuke
Matsue, Yuya
Imai, Takumi
Suwa, Satoru
Taguchi, Isao
Hisauchi, Itaru
Teragawa, Hiroki
Yazaki, Yoshiyuki
Moroi, Masao
Ohashi, Koichi
Nagatomo, Daisuke
Kubota, Toru
Ijichi, Takeshi
Ikari, Yuji
Yonezu, Keisuke
Takahashi, Naohiko
Toyoda, Shigeru
Toshida, Tsutomu
Suzuki, Hiroshi
Minamino, Tohru
Nogi, Kazutaka
Shiina, Kazuki
Horiuchi, Yu
Tanabe, Kengo
Hachinohe, Daisuke
Kiuchi, Shunsuke
Kusunose, Kenya
Shimabukuro, Michio
Node, Koichi
EUROPEAN HEART JOURNAL, 2024, 45 (42) : 4482 - 4493
[9] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
Jain, Dharmendra
Pandey, Umesh Kumar
Tripathi, Suyash
Kaushley, Abhishek
Verma, Bhupendra
Ghosh, Soumik
Santosh, Krishna Vemuri
Prajapati, Rajpal
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
[10] Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction
Sert, Sena
Karabay, Emre
Gungor, Baris
Yildirimturk, Ozlem
MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 99 - 104

← 1 2 3 4 →